APO Research
Talk to an analyst

APO RESEARCH · REPORT

Psilocybin Assisted Therapy

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Psilocybin Assisted Therapy Market Analysis and Forecast 2026-2032

31 December 2025192 pages

Choose your research edition.

Industry ResearchPsilocybin Assisted Therapy Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Psilocybin Assisted Therapy Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Psilocybin Assisted Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Psilocybin Assisted Therapy Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Psilocybin Assisted Therapy Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Psilocybin Assisted Therapy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Psilocybin Assisted Therapy include ATAI Life Sciences, Compass Pathways, DemeRx, Eleusis, Field Trip, Hikma Pharmaceuticals PLC, Jazz Pharmaceuticals, MindMed and Verrian, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Psilocybin Assisted Therapy, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Psilocybin Assisted Therapy, also provides the sales of main regions and countries. Of the upcoming market potential for Psilocybin Assisted Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Psilocybin Assisted Therapy sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Psilocybin Assisted Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Psilocybin Assisted Therapy sales, projected growth trends, production technology, application and end-user industry.

Psilocybin Assisted Therapy Segment by Company

ATAI Life Sciences

Compass Pathways

DemeRx

Eleusis

Field Trip

Hikma Pharmaceuticals PLC

Jazz Pharmaceuticals

MindMed

Verrian

Pfizer

Psilocybin Assisted Therapy Segment by Type

Natural

Synthetic

Psilocybin Assisted Therapy Segment by Application

Psychiatric Disorders

Anxiety Disorders

Cluster Headaches

Psilocybin Assisted Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psilocybin Assisted Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Psilocybin Assisted Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psilocybin Assisted Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Psilocybin Assisted Therapy in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Psilocybin Assisted Therapy manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Psilocybin Assisted Therapy sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Psilocybin Assisted Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Natural Major Manufacturers Table 3. Synthetic Major Manufacturers Table 4. Global Psilocybin Assisted Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Psychiatric Disorders Major Manufacturers Table 6. Anxiety Disorders Major Manufacturers Table 7. Cluster Headaches Major Manufacturers Table 8. Psilocybin Assisted Therapy Industry Trends Table 9. Psilocybin Assisted Therapy Industry Drivers Table 10. Psilocybin Assisted Therapy Industry Opportunities and Challenges Table 11. Psilocybin Assisted Therapy Industry Restraints Table 12. Global Psilocybin Assisted Therapy Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Psilocybin Assisted Therapy Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Psilocybin Assisted Therapy Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2021-2026) Table 16. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2027-2032) Table 17. Global Psilocybin Assisted Therapy Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Psilocybin Assisted Therapy Sales by Region (2021-2026) & (K Units) Table 19. Global Psilocybin Assisted Therapy Sales by Region (2027-2032) & (K Units) Table 20. Global Psilocybin Assisted Therapy Sales Market Share by Region (2021-2026) Table 21. Global Psilocybin Assisted Therapy Sales Market Share by Region (2027-2032) Table 22. Global Psilocybin Assisted Therapy Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Psilocybin Assisted Therapy Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Psilocybin Assisted Therapy Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Psilocybin Assisted Therapy Sales Market Share by Manufacturers (2021-2026) Table 26. Global Psilocybin Assisted Therapy Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Psilocybin Assisted Therapy Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Psilocybin Assisted Therapy Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Psilocybin Assisted Therapy Manufacturers, Product Type & Application Table 30. Global Psilocybin Assisted Therapy Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Psilocybin Assisted Therapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Psilocybin Assisted Therapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Psilocybin Assisted Therapy Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Psilocybin Assisted Therapy Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2021-2026) Table 37. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2027-2032) Table 38. Global Psilocybin Assisted Therapy Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 40. Global Psilocybin Assisted Therapy Sales by Type (2027-2032) & (K Units) Table 41. Global Psilocybin Assisted Therapy Sales Market Share by Type (2021-2026) Table 42. Global Psilocybin Assisted Therapy Sales Market Share by Type (2027-2032) Table 43. Global Psilocybin Assisted Therapy Price by Type (2021-2026) & (US$/Unit) Table 44. Global Psilocybin Assisted Therapy Price by Type (2027-2032) & (US$/Unit) Table 45. Global Psilocybin Assisted Therapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Psilocybin Assisted Therapy Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Psilocybin Assisted Therapy Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2021-2026) Table 49. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2027-2032) Table 50. Global Psilocybin Assisted Therapy Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 52. Global Psilocybin Assisted Therapy Sales by Application (2027-2032) & (K Units) Table 53. Global Psilocybin Assisted Therapy Sales Market Share by Application (2021-2026) Table 54. Global Psilocybin Assisted Therapy Sales Market Share by Application (2027-2032) Table 55. Global Psilocybin Assisted Therapy Price by Application (2021-2026) & (US$/Unit) Table 56. Global Psilocybin Assisted Therapy Price by Application (2027-2032) & (US$/Unit) Table 57. ATAI Life Sciences Company Information Table 58. ATAI Life Sciences Business Overview Table 59. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolio Table 61. ATAI Life Sciences Recent Development Table 62. Compass Pathways Company Information Table 63. Compass Pathways Business Overview Table 64. Compass Pathways Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Compass Pathways Psilocybin Assisted Therapy Product Portfolio Table 66. Compass Pathways Recent Development Table 67. DemeRx Company Information Table 68. DemeRx Business Overview Table 69. DemeRx Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. DemeRx Psilocybin Assisted Therapy Product Portfolio Table 71. DemeRx Recent Development Table 72. Eleusis Company Information Table 73. Eleusis Business Overview Table 74. Eleusis Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Eleusis Psilocybin Assisted Therapy Product Portfolio Table 76. Eleusis Recent Development Table 77. Field Trip Company Information Table 78. Field Trip Business Overview Table 79. Field Trip Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Field Trip Psilocybin Assisted Therapy Product Portfolio Table 81. Field Trip Recent Development Table 82. Hikma Pharmaceuticals PLC Company Information Table 83. Hikma Pharmaceuticals PLC Business Overview Table 84. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolio Table 86. Hikma Pharmaceuticals PLC Recent Development Table 87. Jazz Pharmaceuticals Company Information Table 88. Jazz Pharmaceuticals Business Overview Table 89. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolio Table 91. Jazz Pharmaceuticals Recent Development Table 92. MindMed Company Information Table 93. MindMed Business Overview Table 94. MindMed Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. MindMed Psilocybin Assisted Therapy Product Portfolio Table 96. MindMed Recent Development Table 97. Verrian Company Information Table 98. Verrian Business Overview Table 99. Verrian Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Verrian Psilocybin Assisted Therapy Product Portfolio Table 101. Verrian Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Pfizer Psilocybin Assisted Therapy Product Portfolio Table 106. Pfizer Recent Development Table 107. North America Psilocybin Assisted Therapy Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Psilocybin Assisted Therapy Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 110. North America Psilocybin Assisted Therapy Sales by Type (2027-2032) & (K Units) Table 111. North America Psilocybin Assisted Therapy Sales Price by Type (2021-2026) & (US$/Unit) Table 112. North America Psilocybin Assisted Therapy Sales Price by Type (2027-2032) & (US$/Unit) Table 113. North America Psilocybin Assisted Therapy Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Psilocybin Assisted Therapy Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 116. North America Psilocybin Assisted Therapy Sales by Application (2027-2032) & (K Units) Table 117. North America Psilocybin Assisted Therapy Sales Price by Application (2021-2026) & (US$/Unit) Table 118. North America Psilocybin Assisted Therapy Sales Price by Application (2027-2032) & (US$/Unit) Table 119. North America Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Psilocybin Assisted Therapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Psilocybin Assisted Therapy Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 123. North America Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 124. North America Psilocybin Assisted Therapy Sales by Country (2027-2032) & (K Units) Table 125. North America Psilocybin Assisted Therapy Sales Price by Country (2021-2026) & (US$/Unit) Table 126. North America Psilocybin Assisted Therapy Sales Price by Country (2027-2032) & (US$/Unit) Table 127. United States Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 128. Canada Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 129. Europe Psilocybin Assisted Therapy Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Psilocybin Assisted Therapy Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 132. Europe Psilocybin Assisted Therapy Sales by Type (2027-2032) & (K Units) Table 133. Europe Psilocybin Assisted Therapy Sales Price by Type (2021-2026) & (US$/Unit) Table 134. Europe Psilocybin Assisted Therapy Sales Price by Type (2027-2032) & (US$/Unit) Table 135. Europe Psilocybin Assisted Therapy Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe Psilocybin Assisted Therapy Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 138. Europe Psilocybin Assisted Therapy Sales by Application (2027-2032) & (K Units) Table 139. Europe Psilocybin Assisted Therapy Sales Price by Application (2021-2026) & (US$/Unit) Table 140. Europe Psilocybin Assisted Therapy Sales Price by Application (2027-2032) & (US$/Unit) Table 141. Europe Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Europe Psilocybin Assisted Therapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Europe Psilocybin Assisted Therapy Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 145. Europe Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 146. Europe Psilocybin Assisted Therapy Sales by Country (2027-2032) & (K Units) Table 147. Europe Psilocybin Assisted Therapy Sales Price by Country (2021-2026) & (US$/Unit) Table 148. Europe Psilocybin Assisted Therapy Sales Price by Country (2027-2032) & (US$/Unit) Table 149. Germany Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 150. France Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 151. U.K. Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 152. Italy Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 153. Netherlands Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 154. Nordic Countries Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 155. China Psilocybin Assisted Therapy Revenue by Type (2021-2026) & (US$ Million) Table 156. China Psilocybin Assisted Therapy Revenue by Type (2027-2032) & (US$ Million) Table 157. China Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 158. China Psilocybin Assisted Therapy Sales by Type (2027-2032) & (K Units) Table 159. China Psilocybin Assisted Therapy Sales Price by Type (2021-2026) & (US$/Unit) Table 160. China Psilocybin Assisted Therapy Sales Price by Type (2027-2032) & (US$/Unit) Table 161. China Psilocybin Assisted Therapy Revenue by Application (2021-2026) & (US$ Million) Table 162. China Psilocybin Assisted Therapy Revenue by Application (2027-2032) & (US$ Million) Table 163. China Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 164. China Psilocybin Assisted Therapy Sales by Application (2027-2032) & (K Units) Table 165. China Psilocybin Assisted Therapy Sales Price by Application (2021-2026) & (US$/Unit) Table 166. China Psilocybin Assisted Therapy Sales Price by Application (2027-2032) & (US$/Unit) Table 167. Asia Psilocybin Assisted Therapy Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Psilocybin Assisted Therapy Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 170. Asia Psilocybin Assisted Therapy Sales by Type (2027-2032) & (K Units) Table 171. Asia Psilocybin Assisted Therapy Sales Price by Type (2021-2026) & (US$/Unit) Table 172. Asia Psilocybin Assisted Therapy Sales Price by Type (2027-2032) & (US$/Unit) Table 173. Asia Psilocybin Assisted Therapy Revenue by Application (2021-2026) & (US$ Million) Table 174. Asia Psilocybin Assisted Therapy Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 176. Asia Psilocybin Assisted Therapy Sales by Application (2027-2032) & (K Units) Table 177. Asia Psilocybin Assisted Therapy Sales Price by Application (2021-2026) & (US$/Unit) Table 178. Asia Psilocybin Assisted Therapy Sales Price by Application (2027-2032) & (US$/Unit) Table 179. Asia Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia Psilocybin Assisted Therapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia Psilocybin Assisted Therapy Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 183. Asia Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 184. Asia Psilocybin Assisted Therapy Sales by Country (2027-2032) & (K Units) Table 185. Asia Psilocybin Assisted Therapy Sales Price by Country (2021-2026) & (US$/Unit) Table 186. Asia Psilocybin Assisted Therapy Sales Price by Country (2027-2032) & (US$/Unit) Table 187. Japan Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 188. South Korea Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 189. India Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 190. Australia Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 191. China Taiwan Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 193. SAMEA Psilocybin Assisted Therapy Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Psilocybin Assisted Therapy Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 196. SAMEA Psilocybin Assisted Therapy Sales by Type (2027-2032) & (K Units) Table 197. SAMEA Psilocybin Assisted Therapy Sales Price by Type (2021-2026) & (US$/Unit) Table 198. SAMEA Psilocybin Assisted Therapy Sales Price by Type (2027-2032) & (US$/Unit) Table 199. SAMEA Psilocybin Assisted Therapy Revenue by Application (2021-2026) & (US$ Million) Table 200. SAMEA Psilocybin Assisted Therapy Revenue by Application (2027-2032) & (US$ Million) Table 201. SAMEA Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 202. SAMEA Psilocybin Assisted Therapy Sales by Application (2027-2032) & (K Units) Table 203. SAMEA Psilocybin Assisted Therapy Sales Price by Application (2021-2026) & (US$/Unit) Table 204. SAMEA Psilocybin Assisted Therapy Sales Price by Application (2027-2032) & (US$/Unit) Table 205. SAMEA Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA Psilocybin Assisted Therapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA Psilocybin Assisted Therapy Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 209. SAMEA Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 210. SAMEA Psilocybin Assisted Therapy Sales by Country (2027-2032) & (K Units) Table 211. SAMEA Psilocybin Assisted Therapy Sales Price by Country (2021-2026) & (US$/Unit) Table 212. SAMEA Psilocybin Assisted Therapy Sales Price by Country (2027-2032) & (US$/Unit) Table 213. Brazil Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 214. Argentina Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 215. Chile Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 216. Colombia Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 217. Peru Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 219. Israel Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 220. UAE Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 221. Turkey Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 222. Iran Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 223. Egypt Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Psilocybin Assisted Therapy Distributors List Table 227. Psilocybin Assisted Therapy Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Psilocybin Assisted Therapy Image Figure 2. Global Psilocybin Assisted Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Psilocybin Assisted Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Natural Image Figure 5. Synthetic Image Figure 6. Global Psilocybin Assisted Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Psilocybin Assisted Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 8. Psychiatric Disorders Image Figure 9. Anxiety Disorders Image Figure 10. Cluster Headaches Image Figure 11. Global Psilocybin Assisted Therapy Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Psilocybin Assisted Therapy Revenue (2021-2032) & (US$ Million) Figure 13. Global Psilocybin Assisted Therapy Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Psilocybin Assisted Therapy Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2021-2032) Figure 16. Global Psilocybin Assisted Therapy Sales (2021-2032) & (K Units) Figure 17. Global Psilocybin Assisted Therapy Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Psilocybin Assisted Therapy Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Psilocybin Assisted Therapy Sales YoY (2021-2032) & (K Units) Figure 20. Europe Psilocybin Assisted Therapy Sales YoY (2021-2032) & (K Units) Figure 21. China Psilocybin Assisted Therapy Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Psilocybin Assisted Therapy Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Psilocybin Assisted Therapy Sales YoY (2021-2032) & (K Units) Figure 24. Global Psilocybin Assisted Therapy Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Psilocybin Assisted Therapy Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Psilocybin Assisted Therapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Psilocybin Assisted Therapy Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2021-2032) Figure 30. Global Psilocybin Assisted Therapy Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Psilocybin Assisted Therapy Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Psilocybin Assisted Therapy Sales Market Share by Type (2021-2032) Figure 33. Global Psilocybin Assisted Therapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Psilocybin Assisted Therapy Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2021-2032) Figure 36. Global Psilocybin Assisted Therapy Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Psilocybin Assisted Therapy Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Psilocybin Assisted Therapy Sales Market Share by Application (2021-2032) Figure 39. North America Psilocybin Assisted Therapy Revenue Share by Type (2021-2032) Figure 40. North America Psilocybin Assisted Therapy Sales Share by Type (2021-2032) Figure 41. North America Psilocybin Assisted Therapy Revenue Share by Application (2021-2032) Figure 42. North America Psilocybin Assisted Therapy Sales Share by Application (2021-2032) Figure 43. North America Psilocybin Assisted Therapy Revenue Share by Country (2021-2032) Figure 44. North America Psilocybin Assisted Therapy Sales Share by Country (2021-2032) Figure 45. Europe Psilocybin Assisted Therapy Revenue Share by Type (2021-2032) Figure 46. Europe Psilocybin Assisted Therapy Sales Share by Type (2021-2032) Figure 47. Europe Psilocybin Assisted Therapy Revenue Share by Application (2021-2032) Figure 48. Europe Psilocybin Assisted Therapy Sales Share by Application (2021-2032) Figure 49. Europe Psilocybin Assisted Therapy Revenue Share by Country (2021-2032) Figure 50. Europe Psilocybin Assisted Therapy Sales Share by Country (2021-2032) Figure 51. China Psilocybin Assisted Therapy Revenue Share by Type (2021-2032) Figure 52. China Psilocybin Assisted Therapy Sales Share by Type (2021-2032) Figure 53. China Psilocybin Assisted Therapy Revenue Share by Application (2021-2032) Figure 54. China Psilocybin Assisted Therapy Sales Share by Application (2021-2032) Figure 55. Asia Psilocybin Assisted Therapy Revenue Share by Type (2021-2032) Figure 56. Asia Psilocybin Assisted Therapy Sales Share by Type (2021-2032) Figure 57. Asia Psilocybin Assisted Therapy Revenue Share by Application (2021-2032) Figure 58. Asia Psilocybin Assisted Therapy Sales Share by Application (2021-2032) Figure 59. Asia Psilocybin Assisted Therapy Revenue Share by Country (2021-2032) Figure 60. Asia Psilocybin Assisted Therapy Sales Share by Country (2021-2032) Figure 61. SAMEA Psilocybin Assisted Therapy Revenue Share by Type (2021-2032) Figure 62. SAMEA Psilocybin Assisted Therapy Sales Share by Type (2021-2032) Figure 63. SAMEA Psilocybin Assisted Therapy Revenue Share by Application (2021-2032) Figure 64. SAMEA Psilocybin Assisted Therapy Sales Share by Application (2021-2032) Figure 65. SAMEA Psilocybin Assisted Therapy Revenue Share by Country (2021-2032) Figure 66. SAMEA Psilocybin Assisted Therapy Sales Share by Country (2021-2032) Figure 67. Psilocybin Assisted Therapy Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Psilocybin Assisted Therapy Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Natural
  • Synthetic
Applications
  • Psychiatric Disorders
  • Anxiety Disorders
  • Cluster Headaches
Companies covered
  • ATAI Life Sciences
  • Compass Pathways
  • DemeRx
  • Eleusis
  • Field Trip
  • Hikma Pharmaceuticals PLC
  • Jazz Pharmaceuticals
  • MindMed
  • Verrian
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Psilocybin Assisted Therapy Market by Type
  3. 1.2.1 Global Psilocybin Assisted Therapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Natural
  5. 1.2.3 Synthetic
  6. 1.3 Psilocybin Assisted Therapy Market by Application
  7. 1.3.1 Global Psilocybin Assisted Therapy Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Psychiatric Disorders
  9. 1.3.3 Anxiety Disorders
  10. 1.3.4 Cluster Headaches
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Psilocybin Assisted Therapy Market Dynamics
  1. 2.1 Psilocybin Assisted Therapy Industry Trends
  2. 2.2 Psilocybin Assisted Therapy Industry Drivers
  3. 2.3 Psilocybin Assisted Therapy Industry Opportunities and Challenges
  4. 2.4 Psilocybin Assisted Therapy Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Psilocybin Assisted Therapy Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Psilocybin Assisted Therapy Revenue by Region
  3. 3.2.1 Global Psilocybin Assisted Therapy Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Psilocybin Assisted Therapy Revenue by Region (2021-2026)
  5. 3.2.3 Global Psilocybin Assisted Therapy Revenue by Region (2027-2032)
  6. 3.2.4 Global Psilocybin Assisted Therapy Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Psilocybin Assisted Therapy Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Psilocybin Assisted Therapy Sales by Region
  9. 3.4.1 Global Psilocybin Assisted Therapy Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Psilocybin Assisted Therapy Sales by Region (2021-2026)
  11. 3.4.3 Global Psilocybin Assisted Therapy Sales by Region (2027-2032)
  12. 3.4.4 Global Psilocybin Assisted Therapy Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Psilocybin Assisted Therapy Revenue by Manufacturers
  2. 4.1.1 Global Psilocybin Assisted Therapy Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Psilocybin Assisted Therapy Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Psilocybin Assisted Therapy Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Psilocybin Assisted Therapy Sales by Manufacturers
  6. 4.2.1 Global Psilocybin Assisted Therapy Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Psilocybin Assisted Therapy Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Psilocybin Assisted Therapy Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Psilocybin Assisted Therapy Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Psilocybin Assisted Therapy Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Psilocybin Assisted Therapy Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Psilocybin Assisted Therapy Manufacturers, Product Type & Application
  13. 4.7 Global Psilocybin Assisted Therapy Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Psilocybin Assisted Therapy Market CR5 and HHI
  16. 4.8.2 2025 Psilocybin Assisted Therapy Tier 1, Tier 2, and Tier 3
5 Psilocybin Assisted Therapy Market by Type
  1. 5.1 Global Psilocybin Assisted Therapy Revenue by Type
  2. 5.1.1 Global Psilocybin Assisted Therapy Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Psilocybin Assisted Therapy Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Psilocybin Assisted Therapy Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Psilocybin Assisted Therapy Sales by Type
  6. 5.2.1 Global Psilocybin Assisted Therapy Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Psilocybin Assisted Therapy Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Psilocybin Assisted Therapy Sales Market Share by Type (2021-2032)
  9. 5.3 Global Psilocybin Assisted Therapy Price by Type
6 Psilocybin Assisted Therapy Market by Application
  1. 6.1 Global Psilocybin Assisted Therapy Revenue by Application
  2. 6.1.1 Global Psilocybin Assisted Therapy Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Psilocybin Assisted Therapy Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Psilocybin Assisted Therapy Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Psilocybin Assisted Therapy Sales by Application
  6. 6.2.1 Global Psilocybin Assisted Therapy Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Psilocybin Assisted Therapy Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Psilocybin Assisted Therapy Sales Market Share by Application (2021-2032)
  9. 6.3 Global Psilocybin Assisted Therapy Price by Application
7 Company Profiles
  1. 7.1 ATAI Life Sciences
  2. 7.1.1 ATAI Life Sciences Company Information
  3. 7.1.2 ATAI Life Sciences Business Overview
  4. 7.1.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolio
  6. 7.1.5 ATAI Life Sciences Recent Developments
  7. 7.2 Compass Pathways
  8. 7.2.1 Compass Pathways Company Information
  9. 7.2.2 Compass Pathways Business Overview
  10. 7.2.3 Compass Pathways Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Compass Pathways Psilocybin Assisted Therapy Product Portfolio
  12. 7.2.5 Compass Pathways Recent Developments
  13. 7.3 DemeRx
  14. 7.3.1 DemeRx Company Information
  15. 7.3.2 DemeRx Business Overview
  16. 7.3.3 DemeRx Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 DemeRx Psilocybin Assisted Therapy Product Portfolio
  18. 7.3.5 DemeRx Recent Developments
  19. 7.4 Eleusis
  20. 7.4.1 Eleusis Company Information
  21. 7.4.2 Eleusis Business Overview
  22. 7.4.3 Eleusis Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eleusis Psilocybin Assisted Therapy Product Portfolio
  24. 7.4.5 Eleusis Recent Developments
  25. 7.5 Field Trip
  26. 7.5.1 Field Trip Company Information
  27. 7.5.2 Field Trip Business Overview
  28. 7.5.3 Field Trip Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Field Trip Psilocybin Assisted Therapy Product Portfolio
  30. 7.5.5 Field Trip Recent Developments
  31. 7.6 Hikma Pharmaceuticals PLC
  32. 7.6.1 Hikma Pharmaceuticals PLC Company Information
  33. 7.6.2 Hikma Pharmaceuticals PLC Business Overview
  34. 7.6.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolio
  36. 7.6.5 Hikma Pharmaceuticals PLC Recent Developments
  37. 7.7 Jazz Pharmaceuticals
  38. 7.7.1 Jazz Pharmaceuticals Company Information
  39. 7.7.2 Jazz Pharmaceuticals Business Overview
  40. 7.7.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolio
  42. 7.7.5 Jazz Pharmaceuticals Recent Developments
  43. 7.8 MindMed
  44. 7.8.1 MindMed Company Information
  45. 7.8.2 MindMed Business Overview
  46. 7.8.3 MindMed Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 MindMed Psilocybin Assisted Therapy Product Portfolio
  48. 7.8.5 MindMed Recent Developments
  49. 7.9 Verrian
  50. 7.9.1 Verrian Company Information
  51. 7.9.2 Verrian Business Overview
  52. 7.9.3 Verrian Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Verrian Psilocybin Assisted Therapy Product Portfolio
  54. 7.9.5 Verrian Recent Developments
  55. 7.10 Pfizer
  56. 7.10.1 Pfizer Company Information
  57. 7.10.2 Pfizer Business Overview
  58. 7.10.3 Pfizer Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Pfizer Psilocybin Assisted Therapy Product Portfolio
  60. 7.10.5 Pfizer Recent Developments
8 North America
  1. 8.1 North America Psilocybin Assisted Therapy Market Size by Type
  2. 8.1.1 North America Psilocybin Assisted Therapy Revenue by Type (2021-2032)
  3. 8.1.2 North America Psilocybin Assisted Therapy Sales by Type (2021-2032)
  4. 8.1.3 North America Psilocybin Assisted Therapy Price by Type (2021-2032)
  5. 8.2 North America Psilocybin Assisted Therapy Market Size by Application
  6. 8.2.1 North America Psilocybin Assisted Therapy Revenue by Application (2021-2032)
  7. 8.2.2 North America Psilocybin Assisted Therapy Sales by Application (2021-2032)
  8. 8.2.3 North America Psilocybin Assisted Therapy Price by Application (2021-2032)
  9. 8.3 North America Psilocybin Assisted Therapy Market Size by Country
  10. 8.3.1 North America Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Psilocybin Assisted Therapy Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Psilocybin Assisted Therapy Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Psilocybin Assisted Therapy Market Size by Type
  2. 9.1.1 Europe Psilocybin Assisted Therapy Revenue by Type (2021-2032)
  3. 9.1.2 Europe Psilocybin Assisted Therapy Sales by Type (2021-2032)
  4. 9.1.3 Europe Psilocybin Assisted Therapy Price by Type (2021-2032)
  5. 9.2 Europe Psilocybin Assisted Therapy Market Size by Application
  6. 9.2.1 Europe Psilocybin Assisted Therapy Revenue by Application (2021-2032)
  7. 9.2.2 Europe Psilocybin Assisted Therapy Sales by Application (2021-2032)
  8. 9.2.3 Europe Psilocybin Assisted Therapy Price by Application (2021-2032)
  9. 9.3 Europe Psilocybin Assisted Therapy Market Size by Country
  10. 9.3.1 Europe Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Psilocybin Assisted Therapy Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Psilocybin Assisted Therapy Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Psilocybin Assisted Therapy Market Size by Type
  2. 10.1.1 China Psilocybin Assisted Therapy Revenue by Type (2021-2032)
  3. 10.1.2 China Psilocybin Assisted Therapy Sales by Type (2021-2032)
  4. 10.1.3 China Psilocybin Assisted Therapy Price by Type (2021-2032)
  5. 10.2 China Psilocybin Assisted Therapy Market Size by Application
  6. 10.2.1 China Psilocybin Assisted Therapy Revenue by Application (2021-2032)
  7. 10.2.2 China Psilocybin Assisted Therapy Sales by Application (2021-2032)
  8. 10.2.3 China Psilocybin Assisted Therapy Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Psilocybin Assisted Therapy Market Size by Type
  2. 11.1.1 Asia Psilocybin Assisted Therapy Revenue by Type (2021-2032)
  3. 11.1.2 Asia Psilocybin Assisted Therapy Sales by Type (2021-2032)
  4. 11.1.3 Asia Psilocybin Assisted Therapy Price by Type (2021-2032)
  5. 11.2 Asia Psilocybin Assisted Therapy Market Size by Application
  6. 11.2.1 Asia Psilocybin Assisted Therapy Revenue by Application (2021-2032)
  7. 11.2.2 Asia Psilocybin Assisted Therapy Sales by Application (2021-2032)
  8. 11.2.3 Asia Psilocybin Assisted Therapy Price by Application (2021-2032)
  9. 11.3 Asia Psilocybin Assisted Therapy Market Size by Country
  10. 11.3.1 Asia Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Psilocybin Assisted Therapy Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Psilocybin Assisted Therapy Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Psilocybin Assisted Therapy Market Size by Type
  2. 12.1.1 SAMEA Psilocybin Assisted Therapy Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Psilocybin Assisted Therapy Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Psilocybin Assisted Therapy Price by Type (2021-2032)
  5. 12.2 SAMEA Psilocybin Assisted Therapy Market Size by Application
  6. 12.2.1 SAMEA Psilocybin Assisted Therapy Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Psilocybin Assisted Therapy Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Psilocybin Assisted Therapy Price by Application (2021-2032)
  9. 12.3 SAMEA Psilocybin Assisted Therapy Market Size by Country
  10. 12.3.1 SAMEA Psilocybin Assisted Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Psilocybin Assisted Therapy Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Psilocybin Assisted Therapy Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Psilocybin Assisted Therapy Value Chain Analysis
  2. 13.1.1 Psilocybin Assisted Therapy Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Psilocybin Assisted Therapy Production Mode & Process
  6. 13.2 Psilocybin Assisted Therapy Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Psilocybin Assisted Therapy Distributors
  9. 13.2.3 Psilocybin Assisted Therapy Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst